crossover
    2024

    Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or Inflammation Outcomes in Individuals with Overweight or Obesity

    Tucker RM, Kim N, Gurzell E, Mathi S, Chavva S, Senthilkumar D, et al.

    Published in Nutrients, Vol. 16 (23)

    Methodology

    Randomized, double-blind crossover trial in 34 adults with sleep issues and overweight or obesity who took 500 mg Montmorency capsules or placebo one hour before bed for 14 days; sleep measured by device and validated questionnaires.

    Key Findings

    No significant effect on total, deep or REM sleep, the Pittsburgh Sleep Quality Index, the Insomnia Severity Index, or any inflammatory marker (p > 0.05 for all).

    Conclusions

    A commonly used dose of tart cherry powder did not improve sleep or inflammation in adults with overweight or obesity; higher doses may need testing.

    Limitations

    One dose only; two-week periods.

    Supplements Studied

    No significant effects of MTC supplementation were observed for any of the measures of interest

    Related Health Concerns

    Study Details

    Year:2024
    Sample Size:34
    Duration:2 weeks
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.